Pneumococcal vaccination in inflammatory rheumatic disease. Antibody response and protection against infections.

Medicin och livsvetenskap

• Rheumatic Diseases 100%
• Antibody Formation 84%
• Vaccination 74%
• Infections 44%
• Pneumococcal Infections 38%
• Methotrexate 30%
• belimumab 25%
• Arthritis 20%
• Pneumococcal Vaccines 19%
• Antibodies 17%
• Risk Reduction Behavior 15%
• Streptococcus pneumoniae 15%
• Enzyme-Linked Immunospot Assay 10%
• Antibody-Producing Cells 10%
• Therapeutics 8%
• Immunologic Factors 8%
• Prednisolone 8%
• Microspheres 7%
• International Classification of Diseases 7%
• Immunoassay 7%
• Standard of Care 7%
• Systemic Lupus Erythematosus 7%
• Serogroup 7%
• Rheumatoid Arthritis 6%
• Pneumonia 6%
• Comorbidity 6%
• Vaccines 5%
• Enzyme-Linked Immunosorbent Assay 5%